Zacks: Brokerages Anticipate Cardiff Oncology, Inc. (NASDAQ:CRDF) to Post -$0.25 Earnings Per Share

Equities analysts expect that Cardiff Oncology, Inc. (NASDAQ:CRDF – Get Rating) will post earnings per share of ($0.25) for the current quarter, Zacks Investment Research reports. Two analysts have made estimates for Cardiff Oncology’s earnings, with estimates ranging from ($0.28) to ($0.22). Cardiff Oncology reported earnings of ($0.17) per share during the same quarter last […]

Related Keywords

Florida ,United States ,California ,Blackrock ,Robertw Baird , ,Cardiff Oncology Inc ,Morgan Stanley ,Board Of Administration Florida Retirement System ,Zacks Investment Research ,Blackrock Inc ,Nasdaq ,Invesco Ltd ,Sg Americas Securities ,Maxim Group ,Cardiff Oncology ,Get Rating ,Investment Research ,Florida Retirement System ,Polo Like Kinase ,Nasdaq Crdf ,Acrdf ,Medical ,Ratings ,Consensus ,